Wed. 7 Feb 2024, 4:04pm ET
Benzinga
Earnings, Earnings Beats, News
Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.09) by 55.56 percent. The company reported quarterly sales of $45.27 million which beat the analyst consensus estimate of $37.00 million by 22.35 percent. This is a 29.79 percent decrease over sales of $64.48 million the same period last year.